Browse

Oral Presentation Abstracts

AHNS-061

CHARACTERIZATION OF MALIGNANT PARAGANGLIOMAS OF THE HEAD AND NECK: A MULTI-DECADE EXPERIENCE OF A SINGLE INSTITUTION

Other

Hilary McCrary, MD, MPH1, Patrick Carpenter, MD1, Geoffrey Casazza, MD1, Eric Babajanian, MD1, Anne Naumer, MS2, Samantha Greenberg, MS, MPH2, Wendy Kohlmann, MS2, Richard Cannon, MD1, Marcus M Monroe, MD1, Jason P Hunt, MD1, Luke Buchmann, MD1

1University of Utah Department of Surgery, Division of Otolaryngology, 22University of Utah, Genetic Counseling at the Huntsman Cancer Institute


AHNS-062

PREDICTORS OF DEPRESSION AND ANXIETY IN HEAD AND NECK CANCER PATIENTS

Other

Ashok R Jethwa, Katrina Hueniken, Catriona M Douglas, Geoffrey Liu, Andrew Bayley, Shao Hui Huang, Aaron Hansen, David P Goldstein, Madeline Li, John R de Almeida

Princess Margaret Cancer Center


AHNS-063

QUALITY OF LIFE, TUMOR SITE, AND AGE PREDICT DEPRESSION IN HEAD & NECK CANCER PATIENTS

Other

Carissa M Thomas, MD, PhD1, Jie Su, MSc2, Wei Xu, PhD2, John de Almeida, MD1, Patrick Gullane, MD1, Ralph Gilbert, MD1, Dale Brown, MD1, Jonathan Irish1, Shabbir Alibhai1, David Goldstein1

1University of Toronto, 2Princess Margaret Hospital


AHNS-064

A LONGITUDINAL PROSPECTIVE MIXED MODEL ANALYSIS OF PATIENT REPORTED OUTCOMES AFTER HEAD AND NECK CONFORMAL REIRRADIATION

Radiation Therapy

Courtney Pollard, III, MD, PhD1, Theresa Nguyen, BS1, Sweet P Ng, MBBS1, Gary B Gunn, MD1, Adam S Garden, MD1, Steven J Frank, MD1, Jay P Reddy, MD, PhD1, William H Morrison, MD1, Clifton D Fuller, MD, PhD1, David I Rosenthal, MD1, Charles S Cleeland, PhD2, Tito R Mendoza, PhD2, Jack Phan, MD, PhD1

1Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA, 2Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA


AHNS-065

THE ASSOCIATION BETWEEN PREOPERATIVE FUNCTIONAL PERFORMANCE AND OUTCOMES AFTER SURGICAL TREATMENT OF HEAD AND NECK CANCER

Other

Sampat Sindhar, Dorina Kallogjeri, MD, MPH, Troy S Wildes, MD, Michael S Avidan, MBBCh, FCASA, Jay F Piccirillo, MD, FACS

Washington University in St. Louis, School of Medicine


AHNS-066

VARIATIONS IN HEALTH LITERACY AND FOLLOW-UP AMONG DIFFERENT HEAD AND NECK CANCER SCREENING SITES

Value / Quality

Raquel Zemtsov, MD, MPH1, Gregory Zemtsov, BA2, Meredith Tabangin, MPH3, Mekibib Altaye, PhD3, Alice Tang1

1University of Cincinnati College of Medicine, Department of Otolaryngology - Head and Neck Surgery, 2University of Cincinnati College of Medicine, 3Cincinnati Children's Hospital Medical Center, Division of Biostatistics and Epidemiology


AHNS-067

ELEVATED RISK OF HEAD AND NECK CANCER IN PATIENTS WITH HISTORY OF HEMATOLOGIC MALIGNANCY

Mucosal - HPV Negative

Alia Mowery, BS, Daniel Clayburgh, MD, PhD

Oregon Health and Science University


AHNS-068

COMBINED INHIBITION OF WEE1 AND RAD51 ENHANCES CELL KILLING IN HNSCC

Systemic Therapy / Immunotherapy

Antje Lindemann, Ameeta A Patel, Hideaki Takahashi, Lin Tang, Abdullah A Osman, Jeffrey N Myers

The University of Texas MD Anderson Cancer Center


AHNS-069

ROLE OF INDUCTION CHEMOTHERAPY FOR ORAL CAVITY SQUAMOUS CELL CARCINOMA

Systemic Therapy / Immunotherapy

Ahmed S Abdelmeguid, MD, PhD1, Natalie L Silver, MD, PhD2, Mongkol Boonsripitayanon, MD1, Renata Ferrarotto, MD1, Ann M Gillenwater1, Ehab Y Hanna, MD1

1University of Texas MD Anderson Cancer Center, 2University of Florida College of Medicine


AHNS-070

SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF NF-KB MEDIATED APOPTOSIS OF THE ANTI-INFLAMMATORY BOTANICAL DRUG APG-157 IN PATIENTS WITH ORAL SQUAMOUS CELL CARCINOMA

Systemic Therapy / Immunotherapy

1, Marco Morselli, PhD1, Alakesh Bera, PhD2, Alexander Yoon, BS1, Meera Srivastava, PhD2, Kym F Faull, PhD1, Matteo Pellegrini, PhD1, Chan Jeong, BS1, Eri Srivatsan, PhD3, Marilene B Wang1

1UCLA, 2Uniformed Services University of Health Sciences, 3VA Greater Los Angeles Healthcare System